CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

Study Overview
=================
Brief Summary
-----------------
The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. Identifying these patients and identifying adherence trajectories over time would help mobilize human and telemedicine resources on the patients most in need.

Detailed Description
-----------------
The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with the corresponding weeks during 2019.

Official Title
-----------------
CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

Conditions
-----------------
Sleep Apnea Syndromes

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: patient treated/monitored by the Adene group treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or cardio-metabolic/respiratory comorbidities) associated with symptoms from among sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido disorders, nocturia, choking or suffocation during sleep, daytime tiredness) Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019 continuous PAP during 2019 continuous PAP during 2020 acceptance of PAP telemonitoring with consent given for data collection and data anonymization Exclusion Criteria: less than 360 daily PAP tele-monitored data per year for 2019 less than 360 daily PAP tele-monitored data per year for 2020

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| The study population<br>Patients meeting eligibility criteria (see appropriate section). | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in positive airway pressure(PAP)-adherence during the first lockdown versus corresponding 2019 weeks (h/days) |  | 2020 versus 2019 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in positive airway pressure(PAP)-adherence during the second lockdown versus corresponding 2019 weeks (h/days) |  | 2020 versus 2019 | 
| Change in PAP-adherence 2020 versus 2019 (h/days/weeks) |  | 2020 versus 2019 | 
| Change in the percentage of adherent patients (adherence > 4h/day/week) during the first lockdown versus corresponding 2019 weeks (h/days) |  | 2020 versus 2019 | 
| Change in the percentage of adherent patients (adherence > 4h/day/week) during the second lockdown versus corresponding 2019 weeks (h/days) |  | 2020 versus 2019 | 
| Change in patient adherence 2020 versus 2019 (%). |  | 2020 versus 2019 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Sleep Apnea, Positive Airway Pressure, telemedicine, COVID 19